Enhancer of anticancer activity in viral therapy and method of preventing or treating cancer
US7655459B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Inventor
Key dates
| Filing date | Mar 31, 2005 |
| Grant date | Feb 2, 2010 |
| Priority date | — |
| Expiry date | Jul 27, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16632
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a pharmaceutical that safely and effectively enhances the anticancer activity of viral therapy and particularly the antitumor immunity of viral therapy. The present invention also provides a method of preventing or treating cancer that uses this drug. The anticancer activity enhancer according to the present invention contains interleukin as an effective component and is co-administered with a recombinant herpes simplex virus that selectively replicates in cancer cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.